Literature DB >> 29566921

Epidemiology of skin cancer in the mature patient.

Vivien Lai1, William Cranwell2, Rodney Sinclair3.   

Abstract

Epidermal cancers include keratinocyte cancer, melanocyte cancer, and Merkel cell carcinoma. These cancers account for the vast majority of new cancers diagnosed in Australia, North America, and Europe. Keratinocyte cancer is the most common epidermal cancer and accounts for 7 out of 8 new cancers diagnosed in Australia. Melanoma and Merkel cell carcinoma are less common than keratinocyte carcinoma but are more important causes of mortality in Australia. Keratinocyte cancer has also been demonstrated to be a marker of cancer-prone phenotype. Risk factors for epidermal cancer include intrinsic and environmental factors, in particular exposure to ultraviolet radiation and advanced age. Actinic keratosis has an approximate prevalence of 79% of men and 68% of women between 60 and 69 years of age, and has a low risk of malignant transformation into squamous cell carcinoma. Basal cell carcinoma is the most common malignancy in Caucasians worldwide, with the incidence increasing by 2% per year in Australia. Squamous cell carcinoma is the second most common epidermal cancer, with an incidence of approximately 1035 or 472 per 100,000 person-years in men and women, respectively. Primary risk factors for both basal cell carcinoma and squamous cell carcinoma include light skin color, UV radiation exposure, and chronic immunosuppression. Although the rate of melanoma is increasing, the mortality in Australia is reducing and is currently 9%. The overall incidence of melanoma in Australia is approximately 50 cases per 100,000 persons (62 for men and 40 for women). Keratinocyte carcinoma and melanoma are risk factors for developing further skin cancer and primary malignancy. This contribution reviews the incidence, prevalence, and risk factors associated with the development of epidermal cancer and premalignant epidermal neoplasia.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29566921     DOI: 10.1016/j.clindermatol.2017.10.008

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  24 in total

1.  Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.

Authors:  Joana Lanz; Jan Nico Bouwes Bavinck; Marlies Westhuis; Koen D Quint; Catherine A Harwood; Shaaira Nasir; Vanessa Van-de-Velde; Charlotte M Proby; Carlos Ferrándiz; Roel E Genders; Véronique Del Marmol; Giulia Forchetti; Jürg Hafner; Domenic G Vital; Guenther F L Hofbauer
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice.

Authors:  Abdullah Alyoussef
Journal:  Arch Dermatol Res       Date:  2020-07-07       Impact factor: 3.017

Review 3.  Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.

Authors:  Piyu Parth Naik; Munaf B Desai
Journal:  Oncol Ther       Date:  2022-06-21

4.  Phenylene Bis-Diphenyltriazine (TriAsorB), a new sunfilter protecting the skin against both UVB + UVA and blue light radiations.

Authors:  D Bacqueville; C Jacques-Jamin; H Dromigny; F Boyer; Y Brunel; P J Ferret; D Redoulès; T Douki; S Bessou-Touya; H Duplan
Journal:  Photochem Photobiol Sci       Date:  2021-10-13       Impact factor: 3.982

5.  A Conservative Combined Laser Cryoimmunotherapy Treatment vs. Surgical Excision for Basal Cell Carcinoma.

Authors:  Lucian G Scurtu; Marian Petrica; Mariana Grigore; Alina Avram; Ionel Popescu; Olga Simionescu
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

6.  Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.

Authors:  Magdalena Claeson; Nirmala Pandeya; Jean-Claude Dusingize; Bridie S Thompson; Adele C Green; Rachel E Neale; Catherine M Olsen; David C Whiteman
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

7.  Cohort Study of Nonmelanoma Skin Cancer and the Risk of Exfoliation Glaucoma.

Authors:  Jae H Kang; Trang VoPham; Francine Laden; Bernard A Rosner; Barbara Wirostko; Robert Ritch; Janey L Wiggs; Abrar Qureshi; Hongmei Nan; Louis R Pasquale
Journal:  J Glaucoma       Date:  2020-06       Impact factor: 2.503

8.  Dermoscopic features of basal cell carcinoma and its subtypes: A systematic review.

Authors:  Ofer Reiter; Ilit Mimouni; Stephen Dusza; Allan C Halpern; Yael Anne Leshem; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2019-11-07       Impact factor: 15.487

Review 9.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

10.  Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan.

Authors:  Firas Al-Qarqaz; Maha Marji; Khaldon Bodoor; Rowida Almomani; Wisam Al Gargaz; Diala Alshiyab; Jihan Muhaidat; Mohammad Alqudah
Journal:  J Skin Cancer       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.